Caribou Biosciences, Inc.
CRBU- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001619856
No open-market purchases or sales by Caribou Biosciences, Inc. insiders were filed in the last 90 days; 137 institutions reported holding it in 13F filings for Q2 2026, worth $84.8M in total; Maverick Capital is the only superinvestor holding it.
13F holders, Q1 2022
Institutional positions in Caribou Biosciences, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 104
- +12 vs. Q4 2021
- Shares held
- 34.1M
- +3.06M (+9.8%) vs. Q4 2021
- Total value
- $313.2M
- −$151.3M (−32.6%) vs. Q4 2021
- New holders
- 23
- 43 more added
- Sold out
- 11
- 18 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRBU on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 137 | $84.8M |
| Q1 2026 | 137 | $71.3M |
| Q4 2025 | 124 | $58.8M |
| Q3 2025 | 117 | $87.0M |
| Q2 2025 | 129 | $51.2M |
| Q1 2025 | 131 | $45.8M |
| Q4 2024 | 133 | $93.1M |
| Q3 2024 | 129 | $103.1M |
| Q2 2024 | 140 | $87.6M |
| Q1 2024 | 151 | $343.0M |
| Q4 2023 | 144 | $395.8M |
| Q3 2023 | 126 | $338.5M |
| Q2 2023 | 121 | $185.5M |
| Q1 2023 | 126 | $238.3M |
| Q4 2022 | 133 | $273.8M |
| Q3 2022 | 113 | $456.8M |
| Q2 2022 | 120 | $203.0M |
| Q1 2022 | 104 | $313.2M |
| Q4 2021 | 93 | $464.7M |
| Q3 2021 | 88 | $704.7M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Caribou Biosciences, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| PFM Health Sciences, LP | 4,370,545 | $40.1M | 1.55% | +278,236+6.8% | Added |
| BlackRock Inc. | 3,319,182 | $30.5M | 0.00% | +1,556,153+88.3% | Added |
| Avidity Partners Management LP | 2,819,067 | $25.9M | 0.57% | +145,000+5.4% | Added |
| Pictet Asset Management SA | 2,684,548 | $24.6M | 0.03% | +768,117+40.1% | Added |
| Farallon Capital Management, L.L.C. | 2,657,052 | $24.4M | 0.13% | −306,396−10.3% | Reduced |
| FMR LLC | 2,013,033 | $18.5M | 0.00% | −1,310,251−39.4% | Reduced |
| Vanguard Group Inc | 2,001,554 | $18.4M | 0.00% | +1,087,038+118.9% | Added |
| Alkeon Capital Management LLC | 1,223,549 | $11.2M | 0.05% | −23,076−1.9% | Reduced |
| FIL Ltd | 860,667 | $7.90M | 0.01% | 00.0% | Unchanged |
| Rokos Capital Management LLP | 849,334 | $7.90M | 0.79% | +278,975+48.9% | Added |
| State Street Corp | 743,022 | $6.82M | 0.00% | +330,074+79.9% | Added |
| Tekla Capital Management LLC | 699,377 | $6.42M | 0.23% | 00.0% | Unchanged |
| Memorial Sloan Kettering Cancer Center | 674,196 | $6.19M | 7.17% | 00.0% | Unchanged |
| Maverick Capital LtdSuperinvestorMaverick Capital | 652,542 | $5.99M | 0.11% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 648,757 | $5.96M | 0.00% | +287,125+79.4% | Added |
| Adage Capital Partners GP, L.L.C. | 609,067 | $5.59M | 0.01% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 515,758 | $4.74M | 0.00% | +497,692+2,754.9% | Added |
| 72 Investment Holdings, LLC | 474,067 | $4.35M | 4.76% | 00.0% | Unchanged |
| Monashee Investment Management LLC | 470,000 | $4.32M | 1.25% | −34,377−6.8% | Reduced |
| Northern Trust Corp | 403,770 | $3.71M | 0.00% | +219,683+119.3% | Added |
| Citadel Advisors LLC | 357,501 | $3.28M | 0.00% | +206,391+136.6% | Added |
| Point72 Asset Management, L.P. | 289,739 | $2.66M | 0.01% | 00.0% | Unchanged |
| Granahan Investment Management Inc | 286,672 | $2.63M | 0.07% | +204,545+249.1% | Added |
| Goldman Sachs Group Inc | 279,458 | $2.57M | 0.00% | +247,735+780.9% | Added |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 271,430 | $2.49M | 0.11% | 00.0% | Unchanged |
| Millennium Management LLC | 258,266 | $2.37M | 0.00% | +766+0.3% | Added |
| D. E. Shaw & Co., Inc. | 228,027 | $2.09M | 0.00% | +86,666+61.3% | Added |
| Charles Schwab Investment Management Inc | 214,545 | $1.97M | 0.00% | +72,029+50.5% | Added |
| Velan Capital Investment Management LP | 210,695 | $1.93M | 1.79% | 00.0% | Unchanged |
| Morgan Stanley | 202,888 | $1.86M | 0.00% | +99,820+96.8% | Added |
| Nuveen Asset Management, LLC | 192,180 | $1.76M | 0.00% | +129,399+206.1% | Added |
| Shelton Capital Management | 182,000 | $1.67M | 0.06% | 00.0% | Unchanged |
| Regents of the University of California | 181,304 | $1.66M | 0.25% | +181,304 | New |
| Mirae Asset Global Investments Co., Ltd. | 151,165 | $1.39M | 0.00% | −27,748−15.5% | Reduced |
| Renaissance Technologies LLC | 145,100 | $1.33M | 0.00% | +49,151+51.2% | Added |
| Bank of New York Mellon Corp | 141,262 | $1.30M | 0.00% | +73,427+108.2% | Added |
| Janus Henderson Group PLC | 136,802 | $1.25M | 0.00% | −1,035,923−88.3% | Reduced |
| Cubist Systematic Strategies, LLC | 107,519 | $987.0K | 0.01% | +106,419+9,674.5% | Added |
| Artal Group S.A. | 105,347 | $967.0K | 0.04% | −300,000−74.0% | Reduced |
| Laurion Capital Management LP | 101,600 | $933.0K | 0.02% | −13,400−11.7% | Reduced |
| Stansberry Asset Management, LLC | 92,789 | $852.0K | 0.15% | +25,418+37.7% | Added |
| EcoR1 Capital, LLC | 75,000 | $689.0K | 0.02% | 00.0% | Unchanged |
| Vident Investment Advisory, LLC | 72,366 | $664.0K | 0.02% | +12,060+20.0% | Added |
| Ensign Peak Advisors, Inc | 70,608 | $648.0K | 0.00% | +5,820+9.0% | Added |
| Woodline Partners LP | 68,802 | $632.0K | 0.01% | 00.0% | Unchanged |
| Nelson Capital Management, LLC | 64,858 | $595.0K | 0.12% | +64,858 | New |
| New York State Common Retirement Fund | 64,137 | $589.0K | 0.00% | +42,690+199.0% | Added |
| Swiss National Bank | 57,000 | $523.0K | 0.00% | +4,200+8.0% | Added |
| Qube Research & Technologies Ltd | 50,258 | $461.0K | 0.00% | +50,258 | New |
| Green Alpha Advisors, LLC | 49,674 | $456.0K | 0.31% | +14,082+39.6% | Added |
| Rhumbline Advisers | 48,358 | $444.0K | 0.00% | +28,633+145.2% | Added |
| California State Teachers Retirement System | 42,132 | $387.0K | 0.00% | +10,643+33.8% | Added |
| Tudor Investment Corp Et Al | 33,740 | $310.0K | 0.01% | +3,719+12.4% | Added |
| MetLife Investment Management | 31,003 | $284.6K | 0.00% | +23,472+311.7% | Added |
| UBS Asset Management Americas Inc | 30,300 | $278.2K | 0.00% | +30,300 | New |
| Deutsche Bank AG | 27,126 | $249.0K | 0.00% | +14,112+108.4% | Added |
| Susquehanna International Group, LLP | 25,230 | $232.0K | 0.00% | +10,767+74.4% | Added |
| American International Group, Inc. | 25,253 | $232.0K | 0.00% | +14,477+134.3% | Added |
| State of Wisconsin Investment Board | 25,100 | $230.0K | 0.00% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 25,021 | $230.0K | 0.03% | +25,021 | New |
| Occudo Quantitative Strategies LP | 24,960 | $229.0K | 0.02% | +24,960 | New |
| Two Sigma Investments, LP | 24,456 | $225.0K | 0.00% | +24,456 | New |
| Citigroup Inc | 22,489 | $206.0K | 0.00% | −8,007−26.3% | Reduced |
| Franklin Resources Inc | 21,450 | $197.0K | 0.00% | +21,450 | New |
| Manufacturers Life Insurance Company, The | 20,549 | $188.6K | 0.00% | +9,637+88.3% | Added |
| Bank of America Corp | 19,576 | $180.0K | 0.00% | −70,566−78.3% | Reduced |
| Credit Suisse AG | 18,715 | $172.0K | 0.00% | +2,252+13.7% | Added |
| Jump Financial, LLC | 16,400 | $151.0K | 0.01% | +16,400 | New |
| ProShare Advisors LLC | 15,766 | $145.0K | 0.00% | +2,856+22.1% | Added |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 15,652 | $144.0K | 0.00% | +1,730+12.4% | Added |
| UBS Group AG | 15,641 | $143.0K | 0.00% | −2,293−12.8% | Reduced |
| Schonfeld Strategic Advisors LLC | 14,800 | $136.0K | 0.00% | +14,800 | New |
| Wells Fargo & Company | 14,612 | $134.0K | 0.00% | −11,448−43.9% | Reduced |
| Erste Asset Management GmbH | 13,900 | $128.6K | 0.00% | +13,900 | New |
| Trexquant Investment LP | 13,981 | $128.0K | 0.01% | +13,981 | New |
| Invesco Ltd. | 12,113 | $110.0K | 0.00% | +12,113 | New |
| Balyasny Asset Management LLC | 11,812 | $108.0K | 0.00% | +11,812 | New |
| Legal & General Group Plc | 11,233 | $103.0K | 0.00% | +3,080+37.8% | Added |
| LMR Partners LLP | 10,000 | $92.0K | 0.00% | 00.0% | Unchanged |
| Virtus ETF Advisers LLC | 9,392 | $86.0K | 0.04% | −557−5.6% | Reduced |
| Barclays PLC | 8,369 | $77.0K | 0.00% | +8,369 | New |
| Allspring Global Investments Holdings, LLC | 8,043 | $73.0K | 0.00% | −14,120−63.7% | Reduced |
| Penserra Capital Management LLC | 6,668 | $61.0K | 0.00% | +6,668 | New |
| Amalgamated Bank | 4,851 | $45.0K | 0.00% | +4,851 | New |
| Amalgamated Financial Corp. | 4,851 | $45.0K | 0.00% | +4,851 | New |
| Royal Bank of Canada | 4,724 | $44.0K | 0.00% | +966+25.7% | Added |
| Tower Research Capital LLC (TRC) | 4,681 | $43.0K | 0.00% | +2,021+76.0% | Added |
| STRS Ohio | 4,400 | $40.0K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 3,945 | $36.0K | 0.00% | +2,475+168.4% | Added |
| Metropolitan Life Insurance Co | 3,632 | $33.3K | 0.00% | −2,065−36.2% | Reduced |
| Simplex Trading, LLC | 2,688 | $24.0K | 0.00% | −1,418−34.5% | Reduced |
| Point72 Hong Kong Ltd | 2,063 | $19.0K | 0.00% | +2,063 | New |
| Herold Advisors, Inc. | 1,750 | $16.1K | 0.01% | +1,750 | New |
| Dark Forest Capital Management LP | 1,472 | $13.0K | 0.00% | +1,472 | New |
| Advisor Group Holdings, Inc. | 793 | $7.00K | 0.00% | −103−11.5% | Reduced |
| Allworth Financial LP | 530 | $5.00K | 0.00% | +530 | New |
| Daiwa Securities Group Inc. | 176 | $2.00K | 0.00% | 00.0% | Unchanged |
| Piscataqua Savings Bank | 250 | $2.00K | 0.00% | +100+66.7% | Added |
| The PNC Financial Services Group, Inc. | 100 | $1.00K | 0.00% | 00.0% | Unchanged |
| TCI Wealth Advisors, Inc. | 100 | $1.00K | 0.00% | 00.0% | Unchanged |